Press Releases

Date Title and Summary
Toggle Summary Accuray Showcases Radiation Therapy Innovations Designed to Enable Better Outcomes with Less Damage, Less Time, and Less Cost, at ASTRO 2020
ASTRO Studies Focused on (Ultra) Hypofractionated Treatments Were Shared, Highlighting Experience of >1,400 Patients SUNNYVALE, Calif. , Nov. 10, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that innovations in hardware and software solutions and clinical data presented
Toggle Summary Accuray Reports First Quarter Fiscal 2021 Financial Results
SUNNYVALE, Calif. , Oct. 29, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the first quarter of fiscal 2021 ended September 30, 2020 .     First Quarter Fiscal 2021 Summary Net revenue of $85.3 million , operating income of $5.5 million Adjusted
Toggle Summary Accuray Announces Agreement with Brainlab to Expand CyberKnife® Platform Treatment Capabilities for the Neuro-Radiosurgery Market
Interoperability between Brainlab and Accuray planning systems using Snke OS, an enterprise health tech platform SUNNYVALE, Calif. , Oct. 28, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a pioneer in the robotic stereotactic radiosurgery (SRS) field announced today a collaboration with
Toggle Summary Accuray Appoints Mike Leischer Vice President and General Manager, Americas Region
SUNNYVALE, Calif. , Oct. 19, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today it has appointed Mike Leischer as its vice president and general manager, Americas (AMS) region, effective immediately. In this role, he will provide leadership of the AMS region commercial teams,
Toggle Summary Accuray To Report First Quarter Fiscal 2021 Financial Results on October 29, 2020
SUNNYVALE, Calif. , Oct. 15, 2020 /PRNewswire/ -- Accuray Incorporated  (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2021, ended September 30, 2020, after the market close on Thursday, October 29, 2020. Management will host a conference call to review the
Toggle Summary Accuray to Host ASTRO Analyst & Investor Meeting on October 26, 2020
SUNNYVALE, Calif. , Oct. 13, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will host an Analyst & Investor Meeting on Monday, October 26 th , 2020 in conjunction with the American Society of Radiation Oncology (ASTRO) Annual Meeting.
Toggle Summary Accuray Radixact® System with Synchrony® Technology Delivers Advanced Cancer Treatments at Multiple Hospitals in Japan
- First lung case in ASIA, and the first liver case in the world, were treated at Takarazuka City Hospital, Hyogo, Japan   - Japanese Red Cross Nagoya Daini Hospital, Aichi, and Kishiwada Tokushukai Hospital, Osaka, Japan, have started treating lung cases SUNNYVALE, Calif. , Sept.
Toggle Summary Accuray to Present at Lake Street Capital Markets' 4th Annual Best Ideas Growth Conference
Virtual event to take place on September 17, 2020 SUNNYVALE, Calif. , Sept. 10, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that Joshua H. Levine , president and chief executive officer and Shig Hamamatsu , chief financial officer will present at the fourth annual Lake
Toggle Summary University Hospital Città della Salute e della Scienza, Turin, Italy is First in EIMEA to Treat Cancer Patients Using the Accuray Radixact® System with Synchrony® Technology
Renowned Hospital in Turin, Italy Uses Innovative Radiation Therapy Delivery System to Expand Options for Advanced Cancer Care to More Patients SUNNYVALE, Calif. , Sept. 1, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the medical care team at University Hospital
Toggle Summary Accuray Reports Fourth Quarter and Fiscal 2020 Financial Results
SUNNYVALE, Calif. , Aug. 13, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2020 .     Q4 Fiscal 2020 and Recent Operating Highlights Gross orders of $94.3 million , including 8 orders from China Net

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.